Impact of pathogen reduction technology on neutralizing antibody titer in COVID-19 convalescent plasma.

Franchini, Massimo; Baldanti, Fausto; Percivalle, Elena; Ferrari, Alessandro; Biasi, Pietro; Liumbruno, Giancarlo Maria; Glingani, Claudia

Franchini, Massimo; Baldanti, Fausto; Percivalle, Elena; Ferrari, Alessandro; Biasi, Pietro; Liumbruno, Giancarlo Maria; Glingani, Claudia.

Franchini M; Department of Hematology and Transfusion Medicine, Carlo Poma Hospital, Mantova, Italy. Electronic address: massimo.franchini@asst-mantova.it.
Baldanti F; Molecular Virology Unit, Microbiology and Virology Department, IRCCS Policlinico San Matteo, Pavia, Italy.
Percivalle E; Molecular Virology Unit, Microbiology and Virology Department, IRCCS Policlinico San Matteo, Pavia, Italy.
Ferrari A; Molecular Virology Unit, Microbiology and Virology Department, IRCCS Policlinico San Matteo, Pavia, Italy.
Biasi P; Department of Hematology and Transfusion Medicine, Carlo Poma Hospital, Mantova, Italy.
Liumbruno GM; Department of Hematology and Transfusion Medicine, Carlo Poma Hospital, Mantova, Italy.
Glingani C; Department of Hematology and Transfusion Medicine, Carlo Poma Hospital, Mantova, Italy.

Transfus Clin Biol ; 29(1): 101-102, 2022 02.

Article in English | MEDLINE | ID: covidwho-1331270

Subject(s)

Antibodies, Neutralizing; COVID-19; Antibodies, Viral; COVID-19/therapy; Humans; Immunization, Passive; SARS-CoV-2; Technology; COVID-19 Serotherapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibodies, Neutralizing / COVID-19 Type of study: Experimental Studies Limits: Humans Language: English Journal: Transfus Clin Biol Journal subject: Hematology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google